Cargando…

Optimisation of b-values for the accurate estimation of the apparent diffusion coefficient (ADC) in whole-body diffusion-weighted MRI in patients with metastatic melanoma

OBJECTIVE: To establish optimised diffusion weightings (‘b-values’) for acquisition of whole-body diffusion-weighted MRI (WB-DWI) for estimation of the apparent diffusion coefficient (ADC) in patients with metastatic melanoma (MM). Existing recommendations for WB-DWI have not been optimised for the...

Descripción completa

Detalles Bibliográficos
Autores principales: Knill, Annemarie K., Blackledge, Matthew D., Curcean, Andra, Larkin, James, Turajlic, Samra, Riddell, Angela, Koh, Dow Mu, Messiou, Christina, Winfield, Jessica M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889461/
https://www.ncbi.nlm.nih.gov/pubmed/36169688
http://dx.doi.org/10.1007/s00330-022-09088-5
Descripción
Sumario:OBJECTIVE: To establish optimised diffusion weightings (‘b-values’) for acquisition of whole-body diffusion-weighted MRI (WB-DWI) for estimation of the apparent diffusion coefficient (ADC) in patients with metastatic melanoma (MM). Existing recommendations for WB-DWI have not been optimised for the tumour properties in MM; therefore, evaluation of acquisition parameters is essential before embarking on larger studies. METHODS: Retrospective clinical data and phantom experiments were used. Clinical data comprised 125 lesions from 14 examinations in 11 patients with multifocal MM, imaged before and/or after treatment with immunotherapy at a single institution. ADC estimates from these data were applied to a model to estimate the optimum b-value. A large non-diffusing phantom was used to assess eddy current–induced geometric distortion. RESULTS: Considering all tumour sites from pre- and post-treatment examinations together, metastases exhibited a large range of mean ADC values, [0.67–1.49] × 10(−3) mm(2)/s, and the optimum high b-value (b(high)) for ADC estimation was 1100 (10th–90th percentile: 740–1790) s/mm(2). At higher b-values, geometric distortion increased, and longer echo times were required, leading to reduced signal. CONCLUSIONS: Theoretical optimisation gave an optimum b(high) of 1100 (10th–90th percentile: 740–1790) s/mm(2) for ADC estimation in MM, with the large range of optimum b-values reflecting the wide range of ADC values in these tumours. Geometric distortion and minimum echo time increase at higher b-values and are not included in the theoretical optimisation; b(high) in the range 750–1100 s/mm(2) should be adopted to maintain acceptable image quality but performance should be evaluated for a specific scanner. KEY POINTS: • Theoretical optimisation gave an optimum high b-value of 1100 (10th–90th percentile: 740–1790) s/mm(2) for ADC estimation in metastatic melanoma. • Considering geometric distortion and minimum echo time (TE), a b-value in the range 750–1100 s/mm(2) is recommended. • Sites should evaluate the performance of specific scanners to assess the effect of geometric distortion and minimum TE. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00330-022-09088-5.